ABSTRACT
Background and Purpose
Our objective was to compare the effectiveness of high-tone power therapy (HiToP) with transcutaneous electrical nerve stimulation (TENS) in managing polyneuropathic pain in diabetic patients.
Materials and Methods
This randomized controlled trial, conducted over 3 months, involved 60 male diabetic patients with controlled T2DM who had received medical treatment. Subjects were randomized into two groups: Group A was subjected to HiToP, and Group B received TENS. Both interventions were administered for 30 min, three times a week.
Evaluation
Primary outcomes included the assessment of polyneuropathic pain using the Pain Pressure Threshold (PTT) algometer, as well as the Douleur Neuropathique en 4 Questions (DN4). Secondary outcomes included quality of life (QoL), measured utilizing the WHOQOL questionnaire; glycated hemoglobin level (HbA1c); and sleep disturbance, assessed via the Insomnia Severity Index. Outcomes were documented at baseline and during the post-intervention period.
Results
The results indicated marked differences between both cohorts’ post-treatment, with mean differences (MD) and 95% CI for DN4, PPT, HbA1c, and insomnia equal to −0.87 (−1.17 to −0.56), 0.3 (0.1 to 0.5), −0.08 (−0.13 to −0.04), and −3.97 (−4.62 to −3.31), respectively. The MD and 95% CI for the QoL domains of social relationships, environmental health, physical health, and psychological health were 7.2 (6.36 to 8.04), 7.13 (6.62 to 7.65), 10.23 (9.17 to 11.3), 14.87 (13.82 to 15.92), and 7.2 (6.36 to 8.04), respectively, indicating a more favorable outcome for Group A.
Discussion
For diabetic patients, HiToP demonstrated significantly superior outcomes over TENS in alleviating polyneuropathic pain, improving sleep quality, lowering HbA1c, and enhancing QoL in males with T2DM.
The present summary is based on the findings reported in the following original publication:
High-Tone Power Therapy Versus Transcutaneous Electrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients
Physiotherapy Research International, 2026.
The findings of this randomized controlled trial highlight the clinical potential of HighTone Therapy (HiToP) in improving neuropathic pain, metabolic markers such as HbA1c, sleep quality, and overall quality of life in patients with diabetic polyneuropathy.
For healthcare professionals, physiotherapy centers, pain management clinics, and metabolic health specialists across the UAE, HighTone Therapy (HiToP) represents an evidence-based electrotherapy solution supported by peer-reviewed research.
Tapesh Sky Med, as the official representative of GBO Medizintechnik AG (Germany) in Dubai, provides certified HighTone Therapy (HiToP) systems for:
• Physiotherapy and rehabilitation centers
• Pain clinics
• Sports recovery facilities
• Functional and metabolic medicine practices
In addition to clinical systems, we also offer a home-use HiToP device suitable for patients requiring continuous supportive therapy under professional guidance. This makes HighTone Therapy accessible not only in clinical environments but also for supervised personal use at home.
If you are a healthcare provider seeking advanced electrotherapy technology, or a patient looking for a medically approved home-use solution in Dubai and the UAE, we invite you to explore our complete range of HighTone Therapy systems.